US Drug Prices Rise Despite Trump-Era Promises, Senate Report Finds

Analiza editoriala

Bazat pe 1 sursa, 1 articol

A recent Senate report has revealed that some drug companies have continued to raise prices on medications despite pledges made during the Trump administration to lower drug costs. This finding contradicts the intended effects of deals struck with drugmakers during Trump's presidency, which aimed to provide relief to American consumers. The report underscores the ongoing challenges in controlling prescription drug prices in the United States.